|
CrN-coated punches and nitrosamine risk
|
|
0
|
101
|
July 23, 2026
|
|
AI limit for N-nitroso betahistine?
|
|
32
|
4848
|
July 23, 2026
|
|
Establishment of Limits in ppm (mg/kg) for Drug Products
|
|
2
|
285
|
July 22, 2026
|
|
MEGLUMINE (Methylglucamine)
|
|
31
|
4526
|
July 20, 2026
|
|
N-nitrosoproline
|
|
0
|
120
|
July 20, 2026
|
|
Determining Low PPB Levels of Nitrite in Polymeric Excipients
|
|
2
|
427
|
July 19, 2026
|
|
Less than daily administration
|
|
7
|
496
|
July 19, 2026
|
|
Nitrite Levels in Reverse Osmosis Water
|
|
7
|
440
|
July 17, 2026
|
|
Process-dependent N-nitroso-ketamine formation during ketamine active pharmaceutical ingredient manufacturing: part I impact of process design, solvent selection, and activated carbon-Pub
|
|
1
|
181
|
July 15, 2026
|
|
Trace-level LC–MS/MS quantification of two nitrosamine impurities formed from terazosin-related impurities in pharmaceutical products and greenness assessment-Pub
|
|
2
|
224
|
July 15, 2026
|
|
Requirements for NAs assessment in Russia
|
|
8
|
482
|
July 10, 2026
|
|
In Vitro Metabolism Study of NDSRIs
|
|
4
|
446
|
July 9, 2026
|
|
Research on Nitrosamines in Complex Preparations
|
|
4
|
404
|
July 8, 2026
|
|
Another Prazosin recall linked to N-nitroso-prazosin impurity C raises renewed concern for the finished product
|
|
10
|
921
|
July 7, 2026
|
|
Peptide Synthesis - Does anyone have experience with potential Nitrosamine impurities coming from solid phase synthesis?
|
|
2
|
321
|
July 6, 2026
|
|
Risk Evaluation of N-Nitrosamines in Drug-Linker Intermediates Used To Generate Antibody–Drug Conjugates -Pub
|
|
3
|
486
|
July 6, 2026
|
|
N-nitroso-Furosemide
|
|
4
|
791
|
July 6, 2026
|
|
N-Nitroso Desethyl Amiodarone in Amiodarone HCl Tablets by LC-MS/MS Metodu
|
|
5
|
318
|
July 6, 2026
|
|
Analytical Challenges in Quantifier Ion Selection Due to Mass Error Variability
|
|
7
|
382
|
July 2, 2026
|
|
Nitrosamine limits in pediatric populations
|
|
4
|
299
|
June 30, 2026
|
|
Which carcinogenicity study should I use? Automated identification of reliable studies - PUB
|
|
0
|
117
|
June 29, 2026
|
|
🇺🇸 FDA FY26 GDUFA Public Workshop
|
|
21
|
1052
|
June 28, 2026
|
|
👨💻 Determination of nitrite and nitrate in pregelatinized starch by ion chromatography
|
|
0
|
264
|
June 26, 2026
|
|
Indian Pharmacopoeia introduces a new General Chapter on Nitrosamine Impurities in its 2022 edition
|
|
4
|
2095
|
June 26, 2026
|
|
Mutagenic Impurities in USP -future looking
|
|
17
|
1754
|
June 26, 2026
|
|
The Future of Bio/Pharmaceutical Analysis 2026 - Nitrosamines
|
|
4
|
356
|
June 26, 2026
|
|
Regulatory Flexibilities and Clarifications: Chemistry, Manufacturing and Control (CMC) Information for Original First in Human (FIH) Phase 1 INDs
|
|
2
|
397
|
June 25, 2026
|
|
NDSRI growth with respect to age
|
|
12
|
600
|
June 25, 2026
|
|
👨💻 Nitrosamines Conversations -Coming Soon! 🎙
|
|
0
|
152
|
June 25, 2026
|
|
Recrystallization can stop nitrosamine formation in ranitidine hydrochloride - PUB
|
|
1
|
272
|
June 24, 2026
|